Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XS411 in Parkinson's Disease
NCT07080775Phase 2Active, not recruiting
- Sponsor
- XellSmart Biomedical
- Start
- Aug 2025
- Primary completion
- Jul 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of XS-411 in Parkinson's disease (PD), sponsored by XellSmart Biomedical. Started Aug 2025; status: active, not recruiting.
02
Drugs
XS-411
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07080775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07080775.